Glucose infusion test (GIT) compared with the saline dilution technology in recirculation measurements

Area of Science:

• Nephrology
• Vascular Access
• Diagnostic Methods

Background:

• Vascular access recirculation (R) is a critical complication in hemodialysis.
• The Glucose Infusion Test (GIT) is a novel method measuring R via arterial glucose changes post-venous bolus.
• Accurate R measurement is essential for optimizing hemodialysis efficacy and patient outcomes.

Purpose of the Study:

• To compare the diagnostic performance of the Glucose Infusion Test (GIT) against the ultrasound dilution method (HD01).
• To evaluate the sensitivity and specificity of GIT for detecting vascular access recirculation (R) in vitro and in vivo.
• To assess the clinical utility of GIT as a screening tool for hemodialysis patients.

Main Methods:

• In vitro comparison of GIT and HD01 using a simulated recirculation circuit.
• In vivo evaluation in 162 chronic hemodialysis patients with various vascular access types (fistulae, catheters, grafts).
• Determination of optimal sampling times for GIT based on blood flow rates (QB).

Main Results:

• In vitro, GIT exhibited 100% sensitivity and specificity, while HD01 had 91% sensitivity for R=5%.
• Bland-Altman analysis showed minimal bias for GIT (-0.2+/-1.3%) compared to HD01 (1.3+/-2.9%) in vitro.
• In vivo, GIT and HD01 showed high agreement, with GIT detecting 3 cases of low R missed by HD01 (under 5% detection limit).

Conclusions:

• The Glucose Infusion Test (GIT) is a highly accurate screening tool for vascular access recirculation (R).
• GIT demonstrates superior sensitivity compared to the HD01 ultrasound dilution method, especially for low levels of R.
• GIT is simple, user-friendly, inexpensive, and possesses a very low detection threshold, making it ideal for clinical use.